ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
BriaCell Therapeutics Corporation

BriaCell Therapeutics Corporation (BCTX)

0.7844
-0.1367
( -14.84% )
Updated: 14:05:46

Income Statement

Balance Sheet

Cash Flow

Quarter End Jul 2022Oct 2022Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024
CAD ($)CAD ($)CAD ($)CAD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -11.68M-5.4M-4.49M-5.68M-7.71M-8.5M-9.85M-9.27M
Pre Tax Income -15.75M-1.11M-11.88M-4.9M-2.42M5.96M-11.33M1.69M
Net Income -15.75M-1.11M-11.88M-4.9M-2.42M6M-11.3M1.72M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -11.68M-1.29M-4.49M-5.68M-7.71M5.78M-9.85M-9.27M
EBITDA -11.68M-5.4M-4.48M-5.69M-7.71M-8.5M-9.84M-9.27M
Year End July 30 2023 20162017201820192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -2.18M-2.7M-4.13M-5.54M-2.95M-5.55M-15.29M-23.27M
Pre Tax Income -2.21M-3.22M-5.41M-5.79M-4.03M-428k-26.84M-20.3M
Net Income -2.21M-3.22M-5.41M-5.79M-4.03M-428k-26.84M-20.3M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.024-0.03-0.034-0.029-5.575-0.028-1.73-1.27
EBIT -2.2M-2.7M-4.54M-5.12M-2.93M3.21M-15.29M-23.27M
EBITDA -2.18M-2.7M-4.11M-5.52M-2.93M-5.54M-15.27M-23.27M